Tumor Necrosis Factor Alpha Inhibitors as Immunomodulatory Antirejection Agents after Intestinal Transplantation
Open Access
- 1 May 2011
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 11 (5), 1041-1050
- https://doi.org/10.1111/j.1600-6143.2011.03497.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Inhibition of TNF-α reduces transplant arteriosclerosis in a murine aortic transplant modelTransplant International, 2009
- Present status and future perspectives of intestinal transplantationTransplant International, 2008
- An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody statusClinical Rheumatology, 2008
- Klinische Ergebnisse der Dünndarm- und Multiviszeraltransplantation an der Berliner CharitéDeutsche Medizinische Wochenschrift (1946), 2005
- Infliximab Maintenance Therapy for Fistulizing Crohn's DiseaseThe New England Journal of Medicine, 2004
- Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibodyBone Marrow Transplantation, 2001
- THE EXTRACELLULAR MATRIXTransplantation, 1998
- The Future Role of Anti???Tumour Necrosis Factor-?? Products in the Treatment of Crohn??s DiseaseDrugs, 1998
- Inhibition Of The Effects Of Tnf In Renal Allograft Recipients Using Recombinant Human Dimeric Tumor Necrosis Factor ReceptorsTransplantation, 1995
- Construction and initial characterization of a mouse-human chimeric anti-TNF antibodyMolecular Immunology, 1993